-transparent.png){kind=logo}
Selol is a new organoselenium compound synthesized in the Department of Drug Analysis, Warsaw. The general acute and cumulative toxicities of Selol were tested in rats. The compound did not display any toxic effects after parenteral administration up to 500 mg/kg-1 s.c. and 100 mg/kg-1 i.p. However, given orally it exhibited high toxicity. LD50 value after a single oral administration amounted to 100 mg/kg-1 and after administration in an increasing-dose schedule to 80 mg/kg-1. On the basis of these results the authors conclude that Selol may be converted to a more toxic product during digestion. Therefore, Selol as a source of selenium is safer given by the parenteral route.
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
August 2008,
Neuro endocrinology letters,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
March 1990,
Indian journal of experimental biology,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
June 2010,
Mutation research,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
December 1979,
Indian journal of experimental biology,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
January 1987,
Pharmacology & therapeutics,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
January 1984,
Toxicology and applied pharmacology,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
December 1966,
Australian veterinary journal,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
September 1972,
Archivos latinoamericanos de nutricion,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
July 2012,
Drug and chemical toxicology,
Z Jastrzebski, and
H Czyzewska-Szafran, and
Z Fijatek, and
P Suchocki, and
B A Fitak
October 2016,
Plant signaling & behavior,
